CAS: 502-95-4; Tetrahydro-3,6-Pyridazinedione

该化合物是一个由六人组成的环形环形环状的七环环形有机化合物,内含两个氮原子和两个碳基化合物;该化合物具有双环结构,有助于其独特的化学特性;典型的是一种白色的脱白晶体固体,可溶于极地有机溶剂;碳基组的存在具有回活动性,允许有机合成和药用化学的潜在应用;四氢正丙烯氨-3,6-二酮可以参与各种化学反应,包括核分裂生物学添加和环状添加,使其成为合成复杂分子的多功能中间体;此外,其含氮结构可能会产生生物活动,已在各种研究中探讨过;安全数据表明,与许多有机化合物一样,应当谨慎处理,使用适当的安全措施避免吸入或皮肤接触.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号123-33-1 马来酰肼 | CAS号21827-92-9 n,n'-diacetylgl... | CAS号17973-86-3 3,6-二溴哒嗪 | CAS号3741-24-0 (1,1-Bipyrrolid... | CAS号65886-43-3 1,2-dimethyldia... | CAS号5343-01-1 see Pyridazino[...

合成工艺路线路线简述

    📜抑芽丹置于乙醇,Aluminium Amalgam体系中,化学反应生成 四氢-3,6-吡嗪二酮
    参考文献:The Reactions Of Succinic Anhydride With Hydrazine Hydrate1,2,3
    标题:The Reactions Of Succinic Anhydride With Hydrazine Hydrate1,2,3
    摘要:
    DOI:10.1021/ja01154A068

    海关参考信息

    专利信息


    专利号:US-9850275-B2
    优先权日:2013-09-11
    标 题 :Photolabile linker for the solid-phase synthesis of hydrazides and pyranopyrazoles
    发明人:NIELSEN THOMAS E; QVORTRUP KATRINE
    权利人:UNIV DANMARKS TEKNISKE
    摘要:The photolabile hydrazine linker of the present invention is based on the o-nitro-veratryl group, which is capable of releasing hydrazide derivatives upon UV irradiation. The linker allows for a new solid-phase peptide synthesis (SPPS) strategy which is fully orthogonal to the most commonly used protecting groups and chemical methods in SPPS and shows excellent compatibility with peptide composition, notably the 20 naturally occurring α-amino acid residues (even in their side-chain protected form) are accepted in the C-terminal of the peptide hydrazides. Furthermore, the linker unit can be applied to synthesize combinatorial libraries of biological interesting heterocyclic compounds, such as pyranopyrazoles.

    专利号:US-2010137244-A1
    优先权日:2006-07-13
    标题 :Preparation and utility of hmg-coa reductase inhibitors
    发明人:GANT THOMAS G; SARSHAR SEPEHR
    权利人:AUSPEX PHARMACEUTICALS INC
    摘要:Chemical syntheses and medical uses of novel modulators of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase and diastereomeric mixtures of isomers, individual diastereomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, the chemical synthesis thereof, and the medical use of such compounds for the treatment and/or management of hypercholesterolemia, dyslipidemia, coronary artery disease, atherosclerosis, metabolic syndrome, a hyperproliferative disease such as colorectal cancer, prostate cancer, and melanoma, a neurodegenerative disease such as cerebral ischemia, Alzheimer's disease, and Parkinson's disease are described.

    专利号:EP-3044204-B1
    优先权日:2013-09-11
    标 题 :A photolabile linker for the solid-phase synthesis of hydrazides and pyranopyrazoles

    专利号:US-2023095750-A1
    优先权日:2019-12-12
    标 题:Flow chemistry synthesis of isocyanates
    发明人:BURKART MICHAEL D; PHUNG HAI THIEN AN
    权利人:UNIV CALIFORNIA
    摘要:The disclosure provides, inter alia, safe and environmentally-friendly methods, such as flow chemistry, to synthesize isocyanates, such as methylene diphenyl diisocyanate, toluene diisocyanate, hexamethylene diisocyanate, isophorone diisocyanate, and tetramethylxylene diisocyanate.

    专利号:CA-2922332-A1
    优先权日:2013-09-11
    标 题 :A photolabile linker for the solid-phase synthesis of hydrazides and pyranopyrazoles

    专利号:US-2016272672-A1
    优先权日:2013-09-11
    标题:Photolabile linker for the solid-phase synthesis of hydrazides and pyranopyrazoles

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Haider, N.; Holzer, W., Science of Synthesis, (2004) 16, 373.
    摘要:Maison, W., Science of Synthesis, (2009) 40, 1220.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知